Furthermore, the investigators reported repressed hepatic expression of JMJD3, ATG7, LC3 and ULK1 in MASLD patients, and with the exception of ATG7, our data for MASLD patients agreed with their findings. The gene discussed is MAP1LC3A; the disease is metabolic dysfunction-associated steatotic liver disease.